BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.EBI
The Genomics Institute of The Novartis Research Foundation
Bicyclic carbamates as inhibitors of papain-like cathepsin proteases.EBI
The Genomics Institute of The Novartis Research Foundation
3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists: Part 1.EBI
The Genomics Institute of The Novartis Research Foundation
1,3,5-Trisubstituted aryls as highly selective PPARdelta agonists.EBI
The Genomics Institute of The Novartis Research Foundation
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-EBI
The Genomics Institute of The Novartis Research Foundation
Efficacy and Tolerability of Pyrazolo[1,5-EBI
The Genomics Institute of The Novartis Research Foundation
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo.EBI
The Genomics Institute of The Novartis Research Foundation